Corbus Pharmaceuticals(CRBP) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Norwood, MA, November 12, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage oncology and obesity company, today provided a corporate update and reported financial results for the quarter ended September 30, 2025. "This has been a productive period for Corbus, led by the presentation of CRB-701 data at ESMO 2025," said Yuval ...